- Previous Close
2.9400 - Open
2.8700 - Bid 2.7900 x 500
- Ask 2.8600 x 200
- Day's Range
2.8100 - 2.9100 - 52 Week Range
1.8200 - 4.9000 - Volume
52,202 - Avg. Volume
669,385 - Market Cap (intraday)
99.516M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.5100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.70
Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024. Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas.
www.monogramtechnologies.comRecent News: MGRM
View MorePerformance Overview: MGRM
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MGRM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MGRM
View MoreValuation Measures
Market Cap
103.75M
Enterprise Value
88.46M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
7.16
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-55.72%
Return on Equity (ttm)
-117.05%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-16.33M
Diluted EPS (ttm)
-0.5100
Balance Sheet and Cash Flow
Total Cash (mrq)
15.69M
Total Debt/Equity (mrq)
2.51%
Levered Free Cash Flow (ttm)
-8.9M